Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors.

about

Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumors.

Item

http://www.wikidata.org/entity/Q46039719

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Young donor white blood cell i ...... n advanced-stage solid tumors.

@en

Young donor white blood cell i ...... n advanced-stage solid tumors.

@nl

type

Item

label

Young donor white blood cell i ...... n advanced-stage solid tumors.

@en

Young donor white blood cell i ...... n advanced-stage solid tumors.

@nl

prefLabel

Young donor white blood cell i ...... n advanced-stage solid tumors.

@en

Young donor white blood cell i ...... n advanced-stage solid tumors.

@nl

P1476

Young donor white blood cell i ...... n advanced-stage solid tumors.

@en

P2093

Anthony J Messina

http://www.w3.org/2001/XMLSchema#string

Dipnarine Maharaj

http://www.w3.org/2001/XMLSchema#string

Jacqueline V Gouvea

http://www.w3.org/2001/XMLSchema#string

Pedro G Vianna

http://www.w3.org/2001/XMLSchema#string

Richard D Hammer

http://www.w3.org/2001/XMLSchema#string

Trevor Rayborn

http://www.w3.org/2001/XMLSchema#string

Wendy Ward

http://www.w3.org/2001/XMLSchema#string

Zheng Cui

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction

Cancer immunotherapy: the beginning of the end of cancer?

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction

Novel innate cancer killing activity in humans

Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94.

Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.

P304

e00438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HELIYON.2017.E00438

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29159318

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

lymphocyte

P932

5680985

http://www.w3.org/2001/XMLSchema#string